Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiplatelet activity of β-blockers: new light on existing data.

Literature DB >> 24909390

Antiplatelet activity of β-blockers: new light on existing data.

Pietro Minuz¹, Stefano Calabria, Cristiano Fava.

Abstract

Mesh：

Substances：

Year: 2014 PMID： 24909390 PMCID： PMC4243867 DOI： 10.1111/bcp.12438

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

Keyword Cloud
References

× No keyword cloud information.

12 in total

1. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry.

Authors: Catherine P M Hayward; Karen A Moffat; Anne Raby; Sara Israels; Elizabeth Plumhoff; Greg Flynn; James L Zehnder
Journal: Am J Clin Pathol Date: 2010-12 Impact factor: 2.493

2. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal: J Clin Epidemiol Date: 2009-07-23 Impact factor: 6.437

3. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors: Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal: BMJ Date: 2008-04-26

4. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.

Authors: Turgay Celik; U Cagdas Yuksel; Atila Iyisoy; Hurkan Kursaklioglu; Omer Ozcan; Selim Kilic; Namik Ozmen; Ersoy Isik
Journal: Int J Cardiol Date: 2006-07-05 Impact factor: 4.164

Review 5. Beta blockers, nitric oxide, and cardiovascular disease.

Authors: Paul M Vanhoutte; Yuansheng Gao
Journal: Curr Opin Pharmacol Date: 2013-01-05 Impact factor: 5.547

6. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".

Authors: Francesca Santilli; Bianca Rocca; Raimondo De Cristofaro; Stefano Lattanzio; Laura Pietrangelo; Aida Habib; Caterina Pettinella; Antonio Recchiuti; Elisabetta Ferrante; Giovanni Ciabattoni; Giovanni Davì; Carlo Patrono
Journal: J Am Coll Cardiol Date: 2009-02-24 Impact factor: 24.094

Antiplatelet activity of β-blockers: new light on existing data.

1. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry.

2. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

3. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

4. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.

Review 5. Beta blockers, nitric oxide, and cardiovascular disease.

6. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".

7. Effect of propranolol on platelet function.

8. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.

9. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.

10. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.